MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 13, 2020

Total Value ($000): $163,704 (100.0% shares, 0.0% debt)

Holdings (10)

— Harpoon Therapeutics, Inc. 27.6%

Value ($000) $45,144 Shares 3,898,422 Est. Cost $14.79 Unrealized —

— Epizyme, Inc. 22.1%

Value ($000) $36,162 Shares 2,331,534 Est. Cost $24.60 Unrealized —

— TCR2 Therapeutics, Inc. 15.9%

Value ($000) $26,091 Shares 3,370,982 Est. Cost $14.28 Unrealized —

— G1 Therapeutics, Inc. 9.6%

Value ($000) $15,690 Shares 1,423,794 Est. Cost $26.43 Unrealized —

— Turning Point Therapeutics, Inc. 8.4%

Value ($000) $13,786 Shares 308,686 Est. Cost $44.66 Unrealized —

— MEI Pharma, Inc. 6.1%

Value ($000) $10,063 Shares 6,250,000 Est. Cost $2.48 Unrealized —

— YmAbs Therapeutics, Inc. 5.4%

Value ($000) $8,803 Shares 337,291 Est. Cost $31.25 Unrealized —

CTMX CytomX Therapeutics, Inc. 4.0%

Value ($000) $6,561 Shares 855,437 Est. Cost $6.75 Unrealized +3.3%

— Sunesis Pharmaceuticals, Inc. 0.7%

Value ($000) $1,166 Shares 2,809,912 Est. Cost $0.34 Unrealized —

AUTL Autolus Therapeutics Limited 0.1%

Value ($000) $238 Shares 39,740 Est. Cost $13.21 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Harpoon Therapeutics, Inc.	3,898,422	$45,144	27.6%	$14.79	—	Common	41358P106
—	Epizyme, Inc.	2,331,534	$36,162	22.1%	$24.60	—	Common	29428V104
—	TCR2 Therapeutics, Inc.	3,370,982	$26,091	15.9%	$14.28	—	Common	87808K106
—	G1 Therapeutics, Inc.	1,423,794	$15,690	9.6%	$26.43	—	Common	3621LQ109
—	Turning Point Therapeutics, Inc.	308,686	$13,786	8.4%	$44.66	—	Common	90041T108
—	MEI Pharma, Inc.	6,250,000	$10,063	6.1%	$2.48	—	Common	552798202
—	YmAbs Therapeutics, Inc.	337,291	$8,803	5.4%	$31.25	—	Common	984241109
CTMX	CytomX Therapeutics, Inc.	855,437	$6,561	4.0%	$6.75	+3.3%	Common	23284F105
—	Sunesis Pharmaceuticals, Inc.	2,809,912	$1,166	0.7%	$0.34	—	Common	867328700
AUTL	Autolus Therapeutics Limited	39,740	$238	0.1%	$13.21	—	Common	05280R100